Another theory.
The suitor is Sanofi and they are renegotiating the terms on their contacts as part of entering into a strategic partnership.
Hence no payment coming from Sanofi hence UNS missing their revenue target hence seeking a waiver hence Orbimed loaning another 10MM.
Just a theory.
Begs another question -- why did Orbimed's own due diligence projections fail within a year?
